Corporate Law & Securities
De Lange v. Teva Pharmaceutical Industries Ltd.
marketing practices of opioid based drugs
Motion to disclose documents prior to a derivative action on behalf of Teva, an Israeli public company, traded in TASE and NYSE. According to the motion, which was filed in April 2019, Teva and its subsidiaries face liability in substantial amounts due to marketing practices of opioid based drugs in the US. The applicant claims that Teva's liability might be a result of Teva's board and executive officers failure to reasonably supervise the marketing of these dangerous drugs.
On February 2020 the district court decided to stay the proceedings were stayed, due to parallel proceedings in the United States.
Status: Proceedings are stayed.
Introduce your team! Click here to add images, text and links, or connect data from your collection.